Gujarat Themis Biosyn Ltd. — Major Shareholding Notification 2023

Dec 29, 2023

PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED CIN: U24239MH1991PLC059995

Registered Office: 11/12 Udyog Nagar, S.V. Road, Goregaon West, Mumbai 400 104. Tel: 022- 67607080 E-mail- pbgil.250191@gmail.com/ gtblmumbai@gtbl.in

28[th] December, 2023

The Manager Listing Department BSE Limited ,

P. J. Towers, Dalal Street Mumbai-400001

Dear Sir/Madam,

Sub: Disclosures under Regulation 29 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

In terms of the provision of Regulations 29 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we being a Promoter of Gujarat Themis Biosyn Limited hereby furnish details of sale of shares of Gujarat Themis Biosyn Limited held by us as per the prescribed format enclosed herewith.

We request you to kindly take the same on record.

Thanking you,

Yours faithfully,

For Pharmaceuticals Business Group (India) Limited

JAYSHREE Digitally signed by JAYSHREE DINESH DINESH PATEL Date: 2023.12.28 PATEL 19:33:15 +05'30' Jayshree Patel Director Encl: a/a

CC: The Company Secretary Gujarat Themis Biosyn Limited

FORMAT FOR DISCLOSURES UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011

	Name of the Target Company (TC)	Name of the Target Company (TC)	Name of the Target Company (TC)	Name of the Target Company (TC)	GUJARAT THEMIS BIOSYN LIMITED	GUJARAT THEMIS BIOSYN LIMITED	GUJARAT THEMIS BIOSYN LIMITED	GUJARAT THEMIS BIOSYN LIMITED
	Name(s) of the ~~Concert (PAC)~~			acquirerSELLERand ~~with the acquirer~~	Persons Acting in PHARMACEUTICAL BUSINESS GROUP [INDIA] LTD
	Whether the~~acquirer~~ SELLERbelongs to Promoter / Promoter group						YES
	Name(s) of the Stock Exchange(s) where the shares of TC are Listed						BSE LIMITED
	Details of the		~~acquisition /~~disposal as follows Number				% w. r. t. total share/voti ng capital wherever applicabl e (*)	% w. r. t. total diluted share/voting capital of the TC (**)
	Before the acquisitionDISPOSAL under consideration, holding of : a) Shares carrying voting rights b) Shares in the nature of encumbrance (pledge/ ~~lien/ non-disposal undertaking/ others)~~ c) Voting rights (VR) otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category) e) Total (a+b+c+d) 3,54,60,000^ 17,00,000^ 3,71,60,000^						48.81% 2.34% 51.15%	48.81% 2.34% 51.15%
	a) b) c) d) e)	Details of~~acquisition/~~sale Shares carrying voting rights~~acquired/s~~old VRs acquired /sold otherwise than by shares Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold Shares encumbered / invoked/released by the acquirer Total(a+b+c+/-d)				30,00,000 30,00,000	4.13% 4.13%	4.13% 4.13%

==> picture [481 x 345] intentionally omitted <==

----- Start of picture text -----

After the acquisition/ sale, holding of:
3,41,60,000 47.02% 47.02%
a) Shares carrying voting rights
b) Shares encumbered with the acquirer
c) VRs otherwise than by shares
d) Warrants/convertible securities/any other
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) after acquisition
e) Total (a+b+c+d) 3,41,60,000 47.02% 47.02%
Mode of acquisition / sale (e.g. open market / off-market
/ public issue / rights issue / preferential allotment / inter-se
BLOCK SALE
transfer etc).
Date of acquisition / sale of shares / VR or date of receipt
27 [TH] DECEMBER, 2023
of intimation of allotment of shares, whichever is applicable
NO. OF SHARES: 7,26,43,510 [#]
Equity share capital / total voting capital of the TC before
the said acquisition / sale VALUE OF SHARES: 7,26,43,510 (FV OF Rs. 1/-)
NO. OF SHARES: 7,26,43,510 [#]
Equity share capital/ total voting capital of the TC after
the said acquisition / sale VALUE OF SHARES: 7,26,43,510 (FV OF Rs. 1/-)
NO. OF SHARES: 7,26,43,510 [#]
Total diluted share/voting capital of the TC after the said
VALUE OF SHARES: 7,26,43,510 (FV OF Rs. 1/-)
acquisition / sale
----- End of picture text -----

(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement.

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

( [^] ) Pursuant to Sub-Division (Stock Split) of equity shares of the Company from the Face Value of Rs. 5/- to Face Value of Rs. 1/- per share, the number of shares held by the Promoter, Pharmaceuticals Business Group of (India) Limited (PBG) has been increased to 3,71,60,000 from existing 74,32,000 after the Record Date i.e. 10[th] October, 2023. Also, PBG has recently pledged its 17,00,000 equity shares held in the TC in favour Bajaj Finance Ltd. for providing security for the loan being taken. We understand that above details shall be reflected in the Shareholding Pattern to be submitted by the Company for the quarter ended 31[st] December, 2023.

( [#] ) As per Shareholding pattern submitted the exchange for the quarter ended 30-Sept-2023, total no. of shares held by promoter(s) and Public shareholders was 1,45,28,702. However, as stated above, due to Sub-Division (Stock Split) of equity shares of the Company from the Face Value of Rs. 5/- to Face Value of Rs. 1/- per share and after the Record Date, aggregate number of shares of the Company has been increased to 7,26,43,510 from 1,45,28,702. We understand that after this sale of shares by PBG, there will be no change in the share capital structure of the TC.

JAYSHREE Digitally signed by JAYSHREE DINESH DINESH PATEL Date: 2023.12.28 PATEL 19:33:49 +05'30'

Signature of the ~~acquirer /~~ seller / Authorised Signatory

Place:

Date: